The role of anaerobes in diabetic foot infections

Anaerobe

Volumn 34, Issue , 2015, Pages 8-13

  Charles, Patrick G P ^a,b,c   Uçkay, Ilker ^a   Kressmann, Benjamin ^a   Emonet, Stéphane ^a   Lipsky, Benjamin A ^a,d  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b AUSTIN HEALTH   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Anaerobes; Bacteria; Diabetes mellitus; Diabetic foot infection; Infection; Ulcer

Indexed keywords

ANAEROBE; ANTIBIOTIC THERAPY; BACTEROIDES; DEBRIDEMENT; DIABETIC FOOT; DIABETIC FOOT INFECTION; DISEASE SEVERITY; HUMAN; LEG ISCHEMIA; LEG REVASCULARIZATION; NONHUMAN; PATHOGENESIS; PEPTOSTREPTOCOCCUS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PYROSEQUENCING; REVIEW; TISSUE NECROSIS; ANAEROBIC BACTERIUM; BACTERIAL INFECTIONS; CLASSIFICATION; COMPLICATION; GENETICS; ISOLATION AND PURIFICATION; MICROBIOLOGY; WOUND INFECTION;

BACTEROIDES; PEPTOSTREPTOCOCCUS;

ANTIINFECTIVE AGENT; BACTERIAL DNA; RIBOSOME DNA; RNA 16S;

ANTI-BACTERIAL AGENTS; BACTERIA, ANAEROBIC; BACTERIAL INFECTIONS; DEBRIDEMENT; DIABETIC FOOT; DNA, BACTERIAL; DNA, RIBOSOMAL; HUMANS; RNA, RIBOSOMAL, 16S; WOUND INFECTION;

EID: 84926665067     PISSN: 10759964     EISSN: 10958274     Source Type: Journal    
DOI: 10.1016/j.anaerobe.2015.03.009     Document Type: Review

References (74)

1. Singh N., Armstrong D.G., Lipsky B.A. Preventing foot ulcers in patients with diabetes. JAMA 2005, 293:217-228.
2. Raspovic K.M., Wukich D.K. Self-reported quality of life and diabetic foot infections. J.Foot Ankle Surg. 2014, 53:716-719.
3. Lipsky B.A., Berendt A.R., Cornia P.B., et al. 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin. Infect. Dis. 2012, 54:e132-e173.
4. Louie T.J., Bartlett J.G., Tally F.P., Gorbach S.L. Aerobic and anaerobic bacteria in diabetic foot ulcers. Ann. Intern. Med. 1976, 85:461-463.
5. Gerding D.N. Foot infections in diabetic patients: the role of anaerobes. Clin. Infect. Dis. 1995, 20(Suppl.2):S283-S288.
6. Uçkay I., Gariani K., Pataky Z., Lipsky B.A. Diabetic foot infections: state-of-the-art. Diabetes Obes. Metab. 2014, 16:305-316.
7. Bowler P.G., Duerden B.I., Armstrong D.G. Wound microbiology and associated approaches to wound management. Clin. Microbiol. Rev. 2001, 14:244-269.
8. Lavery L.A., Peters E.J., Armstrong D.G., Wendel C.S., Murdoch D.P., Lipsky B.A. Risk factors for developing osteomyelitis in patients with diabetic foot wounds. Diabetes Res. Clin. Pract. 2009, 83:347-352.
9. Prompers L., Schaper N., Apelqvist J., et al. Prediction of outcome in individuals with diabetic foot ulcers: focus on the differences between individuals with and without peripheral arterial disease. The EURODIALE study. Diabetologia 2008, 51:747-755.
10. Gardner S.E., Hillis S.L., Heilmann K., Segre J.A., Grice E.A. The neuropathic diabetic foot ulcer microbiome is associated with clinical factors. Diabetes 2013, 62:923-930.
11. Chakraborti C., Le C., Yanofsky A. Sensitivity of superficial cultures in lower extremity wounds. J.Hosp. Med. 2010, 5:415-420.
12. Sotto A., Richard J.L., Jourdan N., et al. Miniaturized oligonucleotide arrays: a new tool for discriminating colonization from infection due to Staphylococcus aureus in diabetic foot ulcers. Diabetes Care 2007, 30:2051-2056.
13. Senneville E., Melliez H., Beltrand E., et al. Culture of percutaneous bone biopsy specimens for diagnosis of diabetic foot osteomyelitis: concordance with ulcer swab cultures. Clin. Infect. Dis. 2006, 42:57-62.
14. Senneville E., Morant H., Descamps D., et al. Needle puncture and transcutaneous bone biopsy cultures are inconsistent in patients with diabetes and suspected osteomyelitis of the foot. Clin. Infect. Dis. 2009, 48:888-893.
15. Dowd S.E., Wolcott R.D., Sun Y., McKeehan T., Smith E., Rhoads D. Polymicrobial nature of chronic diabetic foot ulcer biofilm infections determined using bacterial tag encoded FLX amplicon pyrosequencing (bTEFAP). PLoS One 2008, 3:e3326.
16. Dowd S.E., Sun Y., Secor P.R., et al. Survey of bacterial diversity in chronic wounds using pyrosequencing, DGGE, and full ribosome shotgun sequencing. BMC Microbiol. 2008, 8:43.
17. Lavigne J.P., Sotto A., Dunyach-Remy C., Lipsky B.A. New molecular techniques to study the skin microbiota of diabetic foot ulcers. Adv. Wound Care (New Rochelle) 2015, 4:38-49.
18. Spichler A., Hurwitz B.L., Armstrong D.G., Lipsky B.A. Microbiology of diabetic foot infections: from Louis Pasteur to 'crime scene investigation'. BMC Med. 2015, 13:2.
19. Lipsky B.A., Richard J.L., Lavigne J.P. Diabetic foot ulcer microbiome: one small step for molecular microbiology. . . One giant leap for understanding diabetic foot ulcers?. Diabetes 2013, 62:679-681.
20. Zenelaj B., Bouvet C., Lipsky B.A., Uçkay I. Do diabetic foot infections with methicillin-resistant Staphylococcus aureus differ from those with other pathogens?. Int. J. Low Extrem. Wounds 2014, 13:263-272.
21. Hsu Y.M., Burnham C.A. MALDI-TOF MS identification of anaerobic bacteria: assessment of pre-analytical variables and specimen preparation techniques. Diagn. Microbiol. Infect. Dis. 2014, 79:144-148.
22. Nagy E., Schuetz A. Is there a need for the antibiotic susceptibility testing of anaerobic bacteria?. Anaerobe 2015, 31:2-3.
23. Jamal W., Shahin M., Rotimi V.O. Surveillance and trends of antimicrobial resistance among clinical isolates of anaerobes in Kuwait hospitals from 2002 to 2007. Anaerobe 2010, 16:1-5.
24. Bahebeck J., Sobgui E., Loic F., Nonga B.N., Mbanya J.C., Sosso M. Limb-threatening and life-threatening diabetic extremities: clinical patterns and outcomes in 56 patients. J.Foot Ankle Surg. 2010, 49:43-46.
25. Lipsky B.A., Sheehan P., Armstrong D.G., Tice A.D., Polis A.B., Abramson M.A. Clinical predictors of treatment failure for diabetic foot infections: data from a prospective trial. Int. Wound J. 2007, 4:30-38.
26. Lipsky B.A., Armstrong D.G., Citron D.M., Tice A.D., Morgenstern D.E., Abramson M.A. Ertapenem versus piperacillin/tazobactam for diabetic foot infections (SIDESTEP): prospective, randomised, controlled, double-blinded, multicentre trial. Lancet 2005, 366:1695-1703.
27. Lauf L., Ozsvar Z., Mitha I., et al. Phase 3 study comparing tigecycline and ertapenem in patients with diabetic foot infections with and without osteomyelitis. Diagn. Microbiol. Infect. Dis. 2014, 78:469-480.
28. Vardakas K.Z., Horianopoulou M., Falagas M.E. Factors associated with treatment failure in patients with diabetic foot infections: an analysis of data from randomized controlled trials. Diabetes Res. Clin. Pract. 2008, 80:344-351.
29. Clay P.G., Graham M.R., Lindsey C.C., Lamp K.C., Freeman C., Glaros A. Clinical efficacy, tolerability, and cost savings associated with the use of open-label metronidazole plus ceftriaxone once daily compared with ticarcillin/clavulanate every 6 hours as empiric treatment for diabetic lower-extremity infections in older males. Am. J. Geriatr. Pharmacother. 2004, 2:181-189.
30. Lipsky B.A., Baker P.D., Landon G.C., Fernau R. Antibiotic therapy for diabetic foot infections: comparison of two parenteral-to-oral regimens. Clin. Infect. Dis. 1997, 24:643-648.
31. Lipsky B.A., Giordano P., Choudhri S., Song J. Treating diabetic foot infections with sequential intravenous to oral moxifloxacin compared with piperacillin-tazobactam/amoxicillin-clavulanate. J.Antimicrob. Chemother. 2007, 60:370-376.
32. Lipsky B.A., Itani K., Norden C. Treating foot infections in diabetic patients: a randomized, multicenter, open-label trial of linezolid versus ampicillin-sulbactam/amoxicillin-clavulanate. Clin. Infect. Dis. 2004, 38:17-24. Linezolid Diabetic Foot Infections Study G.
33. Lipsky B.A., Pecoraro R.E., Larson S.A., Hanley M.E., Ahroni J.H. Outpatient management of uncomplicated lower-extremity infections in diabetic patients. Arch. Intern. Med. 1990, 150:790-797.
34. Peterson L.R., Lissack L.M., Canter K., Fasching C.E., Clabots C., Gerding D.N. Therapy of lower extremity infections with ciprofloxacin in patients with diabetes mellitus, peripheral vascular disease, or both. Am. J. Med. 1989, 86:801-808.
35. Schaper N.C., Dryden M., Kujath P., et al. Efficacy and safety of IV/PO moxifloxacin and IV piperacillin/tazobactam followed by PO amoxicillin/clavulanic acid in the treatment of diabetic foot infections: results of the RELIEF study. Infection 2013, 41:175-186.
36. Lipsky B.A., Peters E.J., Senneville E., et al. Expert opinion on the management of infections in the diabetic foot. Diabetes Metab. Res. Rev. 2012, 28(Suppl.1):163-178.
37. Anandi C., Alaguraja D., Natarajan V., et al. Bacteriology of diabetic foot lesions. Indian J. Med. Microbiol. 2004, 22:175-178.
38. Unachukwu C.N., Obunge O.K., Odia O.J. The bacteriology of diabetic foot ulcers in Port Harcourt, Nigeria. Niger. J. Med. 2005, 14:173-176.
39. Senneville E. Antimicrobial interventions for the management of diabetic foot infections. Expert Opin. Pharmacother. 2005, 6:263-273.
40. Abdulrazak A., Bitar Z.I., Al-Shamali A.A., Mobasher L.A. Bacteriological study of diabetic foot infections. J.Diabetes Complicat. 2005, 19:138-141.
41. Shankar E.M., Mohan V., Premalatha G., Srinivasan R.S., Usha A.R. Bacterial etiology of diabetic foot infections in South India. Eur. J. Intern. Med. 2005, 16:567-570.
42. Raja N.S. Microbiology of diabetic foot infections in a teaching hospital in Malaysia: a retrospective study of 194 cases. J.Microbiol. Immunol. Infect. 2007, 40:39-44.
43. Cetin M., Ocak S., Kuvandik G., Aslan B. Comparison of bacterial isolates cultured from hemodialysis patients and other patients with diabetic foot and their antimicrobial resistance. Ren. Fail. 2007, 29:973-978.
44. Sotto A., Bouziges N., Jourdan N., Richard J.L., Lavigne J.P. Invitro activity of tigecycline against strains isolated from diabetic foot ulcers. Pathol. Biol. 2007, 55:398-406.
45. Umadevi S., Kumar S., Joseph N.M., et al. Microbiological study of diabetic foot infections. Indian J. Med. Spec. 2007, 2:12-17.
46. Ozkara A., DelibasI T., Selcoki Y., Arikan M.F. The major clinical outcomes of diabetic foot infections: one center experience. Cent. Eur. J. Med. 2008, 3:464-469.
47. Aragón-Sánchez F.J., Cabrera-Galván J.J., Quintana-Marrero Y., et al. Outcomes of surgical treatment of diabetic foot osteomyelitis: a series of 185 patients with histopathological confirmation of bone involvement. Diabetalogia 2008, 51:1962-1970.
48. Ng L.S., Kwang L.L., Yeow S.C., Tan T.Y. Anaerobic culture of diabetic foot infections: organisms and antimicrobial susceptibilities. Ann. Acad. Med. Singap. 2008, 37:936-939.
49. Khoharo H.K., Ansari S., Qureshi F. Diabetic foot ulcers. Prof. Med. J. 2009, 16:53-60.
50. Martinez-Gomez Dde A., Ramirez-Almagro C., Campillo-Soto A., Morales-Cuenca G., Pagan-Ortiz J., Aguayo-Albasini J.L. Diabetic foot infections. Prevalence and antibiotic sensitivity of the causative microorganisms. Enferm. Infecc. Microbiol. Clin. 2009, 27:317-321.
51. Lipsky B.A., Tabak Y.P., Johannes R.S., Vo L., Hyde L., Weigelt J.A. Skin and soft tissue infections in hospitalised patients with diabetes: culture isolates and risk factors associated with mortality, length of stay and cost. Diabetologia 2010, 53:914-923.
52. Girish M.B., Kumar T.N., Srinivas R. Pattern of antimicrobials used to treat infected diabetic foot in a tertiary care hospital in Kolar. Int. J. Pharm. Biomed. Res. 2010, 1:48-52.
53. Zubair M., Malik A., Ahmad J. Clinico-microbiological study and antimicrobial drug resistance profile of diabetic foot infections in North India. Foot (Edinb.) 2011, 21:6-14.
54. Hayat A.S., Khan A.H., Masood N., Shaikh N. Study for microbiological pattern and invitro antibiotic susceptibility in patients having diabetic foot infections at tertiary care hospital in Abbottabad. World Appl. Sci. J. 2011, 12:123-131.
55. Bozkurt F., Gülsün S., Tekin R., Hoşoğlu S., Acemoğlu H. Comparison of microbiological results of deep tissue biopsy and superficial swab in diabetic foot infections. J.Microbiol. Infect. Dis. 2011, 1:122-127.
56. Pappu A.K., Sinha A., Johnson A. Microbiological profile of diabetic foot ulcer. Calicut Med. J. 2011, 9:1-4.
57. Tascini C., Piaggesi A., Tagliaferri E., et al. Microbiology at first visit of moderate-to-severe diabetic foot infection with antimicrobial activity and a survey of quinolone monotherapy. Diabetes Res. Clin. Pract. 2011, 94:133-139.
58. Aziz Z., Lin W.K., Nather A., Huak C.Y. Predictive factors for lower extremity amputations in diabetic foot infections. Diabet. Foot Ankle 2011, 2.
59. Dezfulian A., Salehian M.T., Amini V., et al. Bacteriological study of diabetic foot infections in an Iranian hospital. Iran Red Crescent Med. J. 2011, 13:590-591.
60. Swarna S.R.M.R., Gomathi S., Thamaraiselvi D., Thamaraiselvi S. Astudy of biofilm in diabetic foot ulcer. Int. J. Res. Pharma Biomed. Sci. 2012, 3:1809-1814.
61. Mendes J.J., Marques-Costa A., Vilela C., et al. Clinical and bacteriological survey of diabetic foot infections in Lisbon. Diabetes Res. Clin. Pract. 2012, 95:153-161.
62. Bano I., Chaudhary W.A., Hameed A. Invitro bacteriologic study and empiric antibiotic regimens for diabetic foot ulcers. Afr. J. Microbiol. Res. 2012, 6:5568-5573.
63. Parvez N., Dutta P., Ray P., et al. Microbial profile and utility of soft tissue, pus, and bone cultures in diagnosing diabetic foot infections. Diabetes Technol. Ther. 2012, 14:669-674.
64. Al Benwan K., Al Mulla A., Rotimi V.O. Astudy of the microbiology of diabetic foot infections in a teaching hospital in Kuwait. J.Infect. Public Health 2012, 5:1-8.
65. Osariemen I.J., Olowu S.S., Adevbo E., et al. Aerobic bacteria associated with diabetic wounds in patients attending clinic in a rural community in Nigeria. Glob. Res. J. Microbiol. 2013, 3:8-11.
66. Djahmi N., Messad N., Nedjai S., et al. Molecular epidemiology of Staphylococcus aureus strains isolated from inpatients with infected diabetic foot ulcers in an Algerian University Hospital. Clin. Microbiol. Infect. 2013, 19:E398-E404.
67. Jasmine J., Sekkizhar G., Kumpatla S., Viswanathan V. Bioburden vs. antibiogram of diabetic foot infection. Clin. Res. Foot Ankle 2013, 1:121.
68. Islam S., Cawich S.O., Budhooram S., et al. Microbial profile of diabetic foot infections in Trinidad and Tobago. Prim. Care Diabetes 2013, 7:303-308.
69. Ahmed M.B., Said A.M.I., Naira E.A., Fatani A.J., Emad E.M., Soma A.E. Infection in diabetic foot. Menoufia Med. J. 2013, 26:49-53.
70. Malone M., Bowling F.L., Gannass A., Jude E.B., Boulton A.J. Deep wound cultures correlate well with bone biopsy culture in diabetic foot osteomyelitis. Diabetes Metab. Res. Rev. 2013, 29:546-550.
71. Claros M., Citron D.M., Goldstein E.J., Merriam C.V., Tyrrell K.L. Differences in distribution and antimicrobial susceptibility of anaerobes isolated from complicated intra-abdominal infections versus diabetic foot infections. Diagn. Microbiol. Infect. Dis. 2013, 76:546-548.
72. de Vries M.G., Ekkelenkamp M.B., Peters E.J. Are clindamycin and ciprofloxacin appropriate for the empirical treatment of diabetic foot infections?. Eur. J. Clin. Microbiol. Infect. Dis. 2014, 33:453-456.
73. Hatipoglu M., Mutluoglu M., Uzun G., Karabacak E., Turhan V., Lipsky B.A. The microbiologic profile of diabetic foot infections in Turkey: a 20-year systematic review: diabetic foot infections in Turkey. Eur. J. Clin. Microbiol. Infect. Dis. 2014, 33:871-878.
74. Akhi M.T., Ghotaslou R., Asgharzadeh M., et al. Bacterial etiology and antibiotic susceptibility pattern of diabetic foot infections in Tabriz, Iran. GMS Hyg. Infect. Control 2015, 10. http://www.egms.de/static/pdf/journals/dgkh/2015-10/dgkh000245.pdf.